Status:
WITHDRAWN
GlucoClear ICU Study
Lead Sponsor:
Edwards Lifesciences
Conditions:
Intensive Care Unit Blood Glucose Monitoring
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of this Study is evaluation of the safety and accuracy of the GlucoClear CGM System.
Detailed Description
Design: Non-randomized, non-treatment, prospective, open label Study. The GlucoClear System will not display real-time glucose values, glucose trend graphs, or glucose alarms to either the Study subj...
Eligibility Criteria
Inclusion
- 18 years Surgical ICU or surgical ICU plus intermediate care unit stay ≥ 24 hours Signed consent
Exclusion
- Transplant patient End stage medical conditions or diseases Restricted venous access History of HIT or heparin allergy Contraindication for anti-coagulation Positive pregnancy test In another study
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02238041
Start Date
December 1 2014
End Date
December 1 2015
Last Update
October 1 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.